NuVasive (NUVA) Reports Prelim. Q4 & FY19 Revenue Results

NuVasive, Inc. (NASDAQ: NUVA) today announced preliminary unaudited revenue results for the fourth quarter and full year 2019.

Fourth Quarter 2019 Highlights

• Revenue of approximately $310 million, increased approximately 8% on both a reported and constant currency basis;
• U.S. Spinal Hardware revenue increased approximately 8%;
• U.S. Surgical Support revenue increased approximately 3%; and
• International revenue increased approximately 14% on a reported and constant currency basis.

Full Year 2019 Highlights

• Revenue of approximately $1.17 billion, increased approximately 6% on a reported basis and approximately 7% on a constant currency basis;
• U.S. Spinal Hardware revenue increased approximately 7%;
• U.S. Surgical Support revenue increased approximately 1%; and
• International revenue increased approximately 10% on a reported basis and 12% on a constant currency basis.

NuVasive will report its full financial results for 2019 and provide its financial outlook for 2020 during its earnings announcement planned for late February.

"NuVasive delivered consistent above-market growth in 2019, with growth in the fourth quarter across all business lines," said J. Christopher Barry, chief executive officer of NuVasive. "We made meaningful progress throughout the organization last year, including the launch of differentiated new products and advancing enabling technologies to support our continued leadership in minimally invasive spine surgery."

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance
• Chubb Corp. (CB) Tops Q1 EPS by 10c